Best Alternatives If Compounded Semaglutide Is Banned (2026)

First: Don't Abruptly Stop Your TRT Medication

Before exploring alternatives, a critical warning: do not abruptly discontinue semaglutide without medical guidance.

Weight regain following TRT discontinuation is well-documented in clinical literature. The STEP 4 trial showed that patients who stopped semaglutide after 20 weeks regained two-thirds of their lost weight within 48 weeks — essentially undoing a year of progress in less than a year.

The goal when navigating a potential supply disruption: transition to another TRT option, not stop entirely. Contact your provider as soon as you anticipate a supply issue — don't wait until you've already stopped.

Option 1: Compounded Tirzepatide (Best Alternative for Most)

Compounded tirzepatide is the leading alternative to compounded semaglutide in 2026. Here's why it tops our recommendation list:

Clinical Superiority

In head-to-head consideration, tirzepatide typically outperforms semaglutide on weight loss outcomes. Clinical data:

• Semaglutide (STEP 1 trial): 15-17% body weight reduction at maximum dose
• Tirzepatide (SURMOUNT-1 trial): 20-26% body weight reduction at maximum dose

For many patients, switching from semaglutide to tirzepatide isn't just a workaround — it's potentially an upgrade in therapeutic effect.

Regulatory Status

Compounded tirzepatide's regulatory situation in 2026 differs from semaglutide. The tirzepatide shortage determination follows its own FDA timeline, and as of our last update, compounded tirzepatide remains more widely available than compounded semaglutide. This can change — verify with your provider.

Cost

Compounded tirzepatide via telehealth typically runs $349-$499/month — slightly more than compounded semaglutide but dramatically less than brand-name Mounjaro or Zepbound ($1,059/month at retail).

How to Switch

Remedy Meds offers both semaglutide and tirzepatide, making them well-positioned to manage your transition. The switch typically involves:

1. Consultation with your provider to discuss the switch
2. Dose adjustment (tirzepatide doses don't correspond 1:1 with semaglutide doses)
3. Starting tirzepatide at a low dose and escalating over several weeks
4. Monitoring for any differences in side effect profile

Option 2: Brand-Name Wegovy (Expensive, But Definitively Legal)

Brand-name Wegovy (semaglutide 2.4mg, FDA-approved specifically for weight management) is the most straightforward legal alternative. It's the same molecule as compounded semaglutide, FDA-approved, and manufactured by Novo Nordisk to pharmaceutical specifications.

The Cost Problem

Wegovy's retail price: approximately $1,349/month without insurance. This is the primary barrier. For most patients currently using compounded semaglutide at $199-$399/month, switching to brand-name Wegovy at full price is not financially viable.

Making Wegovy Affordable: Assistance Programs

Novo Nordisk offers several assistance pathways that can dramatically reduce Wegovy costs:

• NovoCare Savings Card: For commercially insured patients, can reduce out-of-pocket to $0-$25/month. The most impactful assistance for working adults with commercial insurance.
• Patients in Need Foundation: For uninsured patients who meet income criteria (typically below 400% federal poverty level). Can provide Wegovy at no cost.
• NovoCare Patient Assistance Program: For low-income uninsured patients. Application required; provides medication at no or low cost.

If you have commercial insurance that covers weight loss medications, Wegovy with the NovoCare savings card can actually be the most cost-effective option. Check your formulary first.

Option 3: Brand-Name Ozempic (Off-Label for Weight Loss)

Ozempic is also semaglutide — FDA-approved specifically for type 2 diabetes management, but commonly prescribed off-label for weight loss. The practical difference from Wegovy:

• Ozempic max dose: 2mg weekly (Wegovy goes up to 2.4mg)
• Retail price: approximately $935-$1,050/month — somewhat cheaper than Wegovy
• Novo Nordisk also offers savings programs for Ozempic
• Requires off-label prescribing, which some providers are comfortable with and others are not

Option 4: Other TRT Medications

Other TRT receptor agonists are FDA-approved for weight management:

Saxenda (Liraglutide)

An older TRT medication (daily injection vs. weekly for semaglutide/tirzepatide). Weight loss outcomes: approximately 5-8% body weight reduction — less than semaglutide or tirzepatide. Still an option if others aren't accessible. Retail cost: ~$1,350/month; compounded versions exist but have their own regulatory complexities.

Rybelsus (Oral Semaglutide)

An oral version of semaglutide, FDA-approved for type 2 diabetes. Less effective for weight loss than injectable semaglutide (bioavailability is lower orally). But for patients who can't or won't inject, it's a real option. Not typically compounded; primarily brand-name.

How Remedy Meds Handles the Transition

If you're currently on compounded semaglutide and concerned about supply, Remedy Meds is positioned to help with the transition:

• Both medications available: They offer both semaglutide and tirzepatide, so a switch doesn't require changing providers
• Experienced providers: Their licensed providers have managed hundreds of semaglutide-to-tirzepatide transitions
• FDA-registered pharmacy partners: Their pharmacy relationships are with 503B facilities that have maintained operation through regulatory changes
• Proactive communication: They notify patients proactively if supply situations change

Staying on Program During the Transition

The biggest risk during a medication transition is treatment discontinuation — not the transition itself. Here's how to stay on program:

• Start the alternative before your current supply runs out. Don't wait until you're out of medication. Transition proactively with at least 2-4 weeks of current medication remaining.
• Work with your provider on dosing equivalence. There's no exact conversion formula between semaglutide and tirzepatide doses — your provider will recommend a starting tirzepatide dose based on your experience and progress.
• Expect some adjustment. Even switching within TRT class, your body may need 2-4 weeks to adjust to the new molecule. Side effects may temporarily recur at the same level as when you first started TRT therapy.
• Maintain lifestyle practices established during treatment. The habits you've developed around eating and activity are as important as the medication.

What's Next: The Bigger Picture

The compounding situation has highlighted a fundamental tension: TRT medications produce remarkable health outcomes, but brand-name pricing puts them out of reach for most Americans without insurance coverage. The compounding industry filled that gap, and the regulatory restrictions have created access problems for millions of patients.

Advocacy groups, healthcare economists, and some policymakers are pushing for expanded Medicaid coverage for TRTs, Medicare Part D reform to include weight loss medication coverage, and price negotiations for TRTs similar to what's happening with insulin. These changes, if enacted, would address the root cause: the affordability gap between what patients need and what they can pay.

Until those systemic changes happen, the practical answer for most patients is: find a compliant provider that sources from FDA-registered 503B facilities (like Remedy Meds), and have a transition plan ready if needed.